Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Disease Progression
Description
The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. MeSH
Hierarchy View
Subtype Terms (2)
Remission, Spontaneous
2 approved drugs
Phase 4 Indicated Drugs (5)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (15)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (37)
Fundacion Investigacion y Desarrollo
Huazhong University of Science and Technology
National Health and Medical Research Council, Australia
Pauls Stradins Clinical University Hospital
Organization Involved with Phase 3 Indications (35)
Organization Involved with Phase 2 Indications (85)
Academic and Community Cancer Research United
Assistance Publique - Hôpitaux de Paris
Evangelisches Studienwerk Villigst
Fondazione Neoplasie Sangue Onlus
Georg Friedrich Rexroth Stiftung, Lohr, Germany
German Leprosy and Tuberculosis Relief Association
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Groupe hospitalier St Joseph-PARIS
Institut de Cancerologie de l'Ouest Paul Papin
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
National Cancer Institute, France
National Cancer Institute (NCI)
National Comprehensive Cancer Network
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Integrative Medicine, Australia
Oregon Health and Science University
Shanghai Junshi Bioscience Co.,Ltd.
Organization Involved with Phase 1 Indications (19)
Organization Involved with Other Experimental Indications (20)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.